Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk　― A Prospective Cohort Study (PENDULUM mono Study) ―

Cohort Study ◽

Antiplatelet Therapy ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk

Circulation Journal ◽

10.1253/circj.cj-20-1058 ◽

2021 ◽

Cited By ~ 1

Author(s):

Masato Nakamura ◽

Kazushige Kadota ◽

Koichi Nakao ◽

Yoshihisa Nakagawa ◽

Junya Shite ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy

JAMA Cardiology ◽

10.1001/jamacardio.2020.0285 ◽

2020 ◽

Vol 5 (8) ◽

pp. 939 ◽

Cited By ~ 2

Author(s):

Roxana Mehran ◽

Jaya Chandrasekhar ◽

Philip Urban ◽

Irene M. Lang ◽

Ute Windhoevel ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Abbreviated Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in High Bleeding Risk Patients

Interventional Cardiology Clinics ◽

10.1016/j.iccl.2020.06.002 ◽

2020 ◽

Vol 9 (4) ◽

pp. 441-449

Author(s):

Matthew J. Price

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Risk Patients ◽

TCT-99 Clinical Outcomes in Patients With High Bleeding Risk and Bifurcations After Percutaneous Coronary Intervention With Resolute Onyx and 1-Month Dual Antiplatelet Therapy

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2021.09.949 ◽

2021 ◽

Vol 78 (19) ◽

pp. B41-B42

Author(s):

Ajay Kirtane ◽

David Kandzari ◽

Azeem Latib ◽

Elvin Kedhi ◽

Roxana Mehran ◽

...

Keyword(s):

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Treated With Short Dual Antiplatelet Therapy: A Recre8 Subanalysis

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2021.06.048 ◽

2021 ◽

Vol 28 ◽

pp. S20-S21

Author(s):

Nicole D. van Hemert ◽

Michiel Voskuil ◽

Rik Rozemeijer ◽

Mèra Stein ◽

Peter Frambach ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Bleeding Risk ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Drug Eluting ◽

Faculty Opinions recommendation of Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158593.618791 ◽

2009 ◽

Author(s):

Ian Beales

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary

A prospective cohort study investigating readmission, symptom attribution and psychological health within six months of primary percutaneous coronary intervention

European Journal of Cardiovascular Nursing ◽

10.1177/1474515114543227 ◽

2014 ◽

Vol 14 (6) ◽

pp. 506-515 ◽

Cited By ~ 7

Author(s):

Heather Iles-Smith ◽

Linda McGowan ◽

Malcolm Campbell ◽

Cat Mercer ◽

Christi Deaton

Keyword(s):

Cohort Study ◽

Prospective Cohort Study ◽

Primary Percutaneous Coronary Intervention ◽

Psychological Health ◽

Prospective Cohort ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Symptom Attribution

Mo1276 – No Differences in Gi Bleeding Risk Between Clopidogrel-, Ticagrelor- Or Prasugrel- Based Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Gastroenterology ◽

10.1016/s0016-5085(19)38791-8 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-743

Author(s):

Viviana Laredo ◽

Sandra Garcia ◽

Nuria Saura ◽

Maria Hernandez Ainsa ◽

Patricia Carrera ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Gi Bleeding ◽

Percutaneous Coronary

PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY AND RISK OF ADVERSE EVENTS IN RELATION TO HIGH BLEEDING RISK AMONG PATIENTS RECEIVING DRUG-ELUTING STENTS: INSIGHTS FROM A LARGE SINGLE-CENTER COHORT STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(20)32004-0 ◽

2020 ◽

Vol 75 (11) ◽

pp. 1377

Author(s):

Haoyu Wang ◽

Kefei Dou ◽

Bo Xu

Keyword(s):

Cohort Study ◽

Adverse Events ◽

Bleeding Risk ◽

Coronary Intervention ◽

Drug Eluting Stents ◽

Single Center ◽

Percutaneous Coronary ◽

Drug Eluting ◽

Access-site complications of transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: a prospective cohort study with radial ultrasound follow-up

Cardiovascular Intervention and Therapeutics ◽

10.1007/s12928-019-00632-7 ◽

2019 ◽

Vol 35 (4) ◽

pp. 343-352

Author(s):

Tsuyoshi Isawa ◽

Kazunori Horie ◽

Masataka Taguri ◽

Tatsushi Ootomo

Keyword(s):

Acute Coronary Syndrome ◽

Cohort Study ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Coronary Intervention ◽

Access Site ◽

Coronary Syndrome ◽

Percutaneous Coronary